Merck, Collaborators Publish Study Showing Potential for Eradication of Persistent HIV Virus in the Body
17:00 EDT 25 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today the publication of a study in the July 26 issue of the
leading scientific journal Nature
that provided early evidence for the use of a drug to...
Other Sources for this Article
Merck
Media:
Ian McConnell, 908-423-3046
or
Investors:
Carol
Ferguson, 908-423-4465
More From BioPortfolio on "Merck, Collaborators Publish Study Showing Potential for Eradication of Persistent HIV Virus in the Body"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
